Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 4Recruiting 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Smoldering Multiple Myeloma 2Prostatic Neoplasms 2Monoclonal Gammopathy of Undetermined Significance 2Uterine Cervical Neoplasms 1Thrombocythemia, Essential 1Stomach Neoplasms 1Psychological Well-Being 1Primary Myelofibrosis 1Polycythemia Vera 1Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Motor Activity 1Lung Neoplasms 1Locally Advanced Cervical Cancer 1Esophageal Neoplasms 1Castration Sensitive Prostate Cancer 1

Interventions

Magnetic Resonance Spectroscopy 51Specimen Handling 42enzalutamide 35Androgen Antagonists 34Radiosurgery 32Radiotherapy 31Prednisone 26darolutamide 24Abiraterone Acetate 24Leuprolide 22Docetaxel 22apalutamide 20Pluvicto 19abiraterone 18Standard of Care 18Triptorelin Pamoate 17Radiation 17Biopsy 16relugolix 15acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 15Goserelin 14Blood Specimen Collection 13gallium 68 PSMA-11 12pembrolizumab 11X-Rays 11Surveys and Questionnaires 11luprolide acetate gel depot 10Carboplatin 10Methods 9Interviews as Topic 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Prostatic Neoplasms × Curcumin × Clear all
NCT02064673 2026-03-30

Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy

University of Texas Southwestern Medical Center

Phase 3 Recruiting
650 enrolled
Genitourinary

Prostatic Neoplasms

NCT03769766 2025-06-11

Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance

University of Texas Southwestern Medical Center

Phase 3 Recruiting
291 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡